论文部分内容阅读
Examination of antioxidant capacity in patients with chronic obstructive pulmonary disease
【机 构】
：
TarbiatModaresUniversityNationalInstituteofGeneticEngineeringandBiotechnology
【出 处】
：
第11届亚太临床生化大会
【发表日期】
：
2007年10期
其他文献
The face of HIV/AIDS is changing.Increasingly,it is a womans face.Six out often new HIV infections are now among women.Womens physiology makes them more vul
会议
Since the discovery of HIV,the causative agent of AIDS,important advances in this field have been made:prevention of the transmission of the agent by blood
会议
The small protein ubiquitin is covalently attached to many cellular proteins in an energy-dependent process.Depending upon the mode of ubiquitin linkage,pro
会议
Resistance of vertebrate hosts against infections comprises important natural of innate immunity combined with adaptive immune responses ofT and B ceils.Vir
会议
Interferon (IFN) was discovered in 1957 and was defined as an antiviral substance.However,people can not get enough IFN materials for research or clinical t
会议
MolecularBreeding? directed molecular evolution expands naturally occurring diversity and allows the identification of protein variants with desirable prope
会议
Historically,the macaque model of HIV pathogenesis has involved use of simian immunodeficiency virus,SIV,and simian human immunodeficiency virus,SHIV.SIV,ex
会议
The development of a prophylactic vaccine to control the HIV pandemic remains a major critical challenge facing the global public health.With more than 40 m
会议
NIFEVIROC,a New and Potent Small-molecule Inhibitor Targeted at the Human Immunodeficiency Virus Typ
NIFEVIROC,a small molecular compound,is a proprietary drug candidate which is developed by TARGETDRUG and holds great promise in inhibiting HIV-1 replicatio
会议